cephalosporin c has been researched along with 2019 Novel Coronavirus Disease in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 20 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benvenuti, MR; Borghesi, L; Franzetti, M; Luzzaro, F; Mauri, C; Moioli, G; Montoli, M; Piconi, S; Viaggi, V | 1 |
| Barbier, F; Buetti, N; Tabah, A; Timsit, JF | 1 |
| Bianco, G; Boattini, M; Casale, R; Cavallo, R; Comini, S; Costa, C; Iannaccone, M | 1 |
| Hiraiwa, T; Kuriyama, N; Matsumoto, K; Nakamura, T; Nishida, O; Yatabe, T | 1 |
| Alby, K; Cowden, L; Cressman, L; Dumm, R; Glaser, L; Gross, R; Jaskowiak-Barr, A; Lautenbach, E; Mannathoko, N; Mokomane, M; Mosepele, M; Otukile, D; Paganotti, GM; Reesey, E; Richard-Greenblatt, M; Sewawa, K; Sharma, A; Smith, RM | 1 |
| Bhattacharya, M; Gaur, S; Sharma, A; Shinde, D; Sindhu, N; Singh, DV | 1 |
| Coronel, P; Domenech, M; Gimeno, M; Llamosí, M; Sempere, J; Yuste, J | 1 |
| Shen, L; Sun, Q; Wang, T; Yin, J; Zhou, L | 1 |
| Abdulla, NM; Bahgat, EA; Ragab, GH; Saleh, HM | 1 |
| Al-Azzam, S; Aldeyab, MA; Araydah, M; Conlon-Bingham, G; Conway, BR; Crowe, W; Darwish Elhajji, F; Ewing, J; Farren, D; Kabbaha, S; Karasneh, RA; Lattyak, WJ; Patterson, L; Sartaj, M; Scott, M | 1 |
| Barata, P; Correia-Neves, M; Domingues, M; Guerreiro, JP; Rocha, J; Sepodes, B; Teixeira Rodrigues, A; Torre, C | 1 |
| Acevedo, J; Araos, R; D'Agata, EMC; Ferreccio, C; González, M; Huidobro, LA; Jara, A; Khan, A; Maureira, L; Munita, JM; Paredes, C; Park, BJ; Peters, A; Rioseco, ML; Rivas, L; Sánchez, F; Sepulveda, D; Smith, RM; Soto, PR; Spencer-Sandino, M; Styczynski, A; Undurraga, E; Usedo, P; Wettig, LR | 1 |
| Matsubara, A; Morita, A; Nakamura, M; Sakaida, T; Tanimoto, I | 1 |
| Abril-Pérez, C; Botella-Estrada, R; Roca-Ginés, J; Sánchez-Arráez, J; Torres-Navarro, I | 1 |
| Benoit, JL; Farley, B; Frohne, C; Hazra, A; McNulty, M; Pettit, N; Pho, M; Pitrak, D; Pursell, K; Ridgway, JP; Saltzman, J; Schmitt, J; Uvin, AZ | 1 |
| Abd El Ghafar, MS; Abd-Elsalam, S; Abdo, EF; Ahmed, OA; Alboraie, M; Esmail, ES; Khalaf, M; Medhat, MA; Serangawy, GN; Soliman, S | 1 |
| Buttazzi, R; Di Mario, S; Gagliotti, C; Moro, ML; Ricchizzi, E; Tedeschi, S | 1 |
| Kumar, R; Kumar, V; Lee, KW | 1 |
| Ali, ST; Cowling, BJ; Hwang, Y; Kim, DS; Klein, EY; Lau, EHY; Ryu, S | 1 |
| Cortes-Lara, S; Del Barrio-Tofiño, E; Gomis-Font, MA; López-Causapé, C; Marco, F; Mulet, X; Oliver, A; Pitart, C; Vila, J; Zboromyrska, Y | 1 |
1 review(s) available for cephalosporin c and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Current opinion in management of septic shock due to Gram-negative bacteria.
Topics: Anti-Bacterial Agents; Cephalosporins; COVID-19; Diagnostic Tests, Routine; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Microbial Sensitivity Tests; Pandemics; SARS-CoV-2; Shock, Septic | 2021 |
1 trial(s) available for cephalosporin c and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
RETRACTED: Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study.
Topics: Acetaminophen; Adult; Antiviral Agents; Betacoronavirus; Cephalosporins; Coronavirus Infections; COVID-19; Drug Administration Schedule; Drug Repositioning; Egypt; Female; Humans; Hydrocortisone; Hydroxychloroquine; Male; Middle Aged; Oseltamivir; Pandemics; Pneumonia, Viral; Respiration, Artificial; SARS-CoV-2; Severity of Illness Index; Survival Analysis; Time Factors; Treatment Outcome | 2020 |
18 other study(ies) available for cephalosporin c and 2019 Novel Coronavirus Disease
| Article | Year |
|---|---|
Successful prolonged cefiderocol treatment of a chronic left pleural empyema caused by Pseudomonas aeruginosa in a patient affected by COVID-19: a case report.
Topics: Cefiderocol; Cephalosporins; COVID-19; Empyema, Pleural; Humans; Pseudomonas aeruginosa; Pseudomonas Infections | 2021 |
Occurrence of multi-carbapenemases producers among carbapenemase-producing Enterobacterales and in vitro activity of combinations including cefiderocol, ceftazidime-avibactam, meropenem-vaborbactam, and aztreonam in the COVID-19 era.
Topics: Anti-Bacterial Agents; Azabicyclo Compounds; Aztreonam; Bacterial Proteins; beta-Lactamases; Boronic Acids; Cefiderocol; Ceftazidime; Cephalosporins; COVID-19; Drug Combinations; Humans; Meropenem; Microbial Sensitivity Tests | 2022 |
Cefepime-induced encephalopathy in a COVID-19 patient: a case report.
Topics: Anti-Bacterial Agents; Brain Diseases; Cefepime; Cephalosporins; COVID-19; COVID-19 Drug Treatment; Humans; Male; Middle Aged | 2022 |
Colonization with extended-spectrum cephalosporin-resistant Enterobacterales (ESCrE) and carbapenem-resistant Enterobacterales (CRE) in healthcare and community settings in Botswana: an antibiotic resistance in communities and hospitals (ARCH) study.
Topics: Adult; Anti-Bacterial Agents; Botswana; Carbapenems; Cephalosporins; Child; Communicable Disease Control; COVID-19; Delivery of Health Care; Drug Resistance, Microbial; Enterobacteriaceae Infections; Hospitals; Humans | 2022 |
COVID-19-related bilateral acute de-pigmentation of iris with ocular hypertension.
Topics: Adult; Anti-Bacterial Agents; Cephalosporins; COVID-19; Glaucoma; Humans; Iris; Male; Ocular Hypertension; Pigmentation; Pigmentation Disorders | 2022 |
Combination of Cefditoren and
Topics: Acetylcysteine; Animals; Anti-Bacterial Agents; Antioxidants; Biofilms; Cephalosporins; COVID-19; Humans; Mice; Respiratory Tract Infections; SARS-CoV-2; Streptococcus pneumoniae | 2022 |
Antibiotic use in township hospitals during the COVID-19 pandemic in Shandong, China.
Topics: Anti-Bacterial Agents; Cephalosporins; China; COVID-19; Drug Utilization; Hospitals; Humans; Pandemics; Penicillins | 2022 |
Green Spectrophotometric Determination of Two Cephalosporin Drugs Used in COVID-19 Regimen Through Silver Nanoparticle Synthesis.
Topics: Anti-Bacterial Agents; Cephalosporins; COVID-19; COVID-19 Drug Treatment; Humans; Metal Nanoparticles; Monobactams; Silver | 2023 |
The impact of the COVID-19 pandemic on antibiotic consumption and prevalence of pathogens in primary and secondary healthcare settings in Northern Ireland.
Topics: Anti-Bacterial Agents; Cephalosporins; COVID-19; Delivery of Health Care; Humans; Northern Ireland; Pandemics; Prevalence | 2023 |
COVID-19 pandemic and the quality of antibiotic use in primary care: an interrupted time-series study.
Topics: Anti-Bacterial Agents; Cephalosporins; COVID-19; Humans; Lincosamides; Macrolides; Pandemics; Penicillins; Primary Health Care; Quinolones; Streptogramins | 2023 |
High Burden of Intestinal Colonization With Antimicrobial-Resistant Bacteria in Chile: An Antibiotic Resistance in Communities and Hospitals (ARCH) Study.
Topics: Adult; Anti-Bacterial Agents; Anti-Infective Agents; Bacteria; Carbapenems; Cephalosporins; Chile; COVID-19; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Hospitals; Humans; Risk Factors | 2023 |
Unique skin manifestations of COVID-19: Is drug eruption specific to COVID-19?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Betacoronavirus; Cephalosporins; Coronavirus Infections; COVID-19; Drug Eruptions; Female; Humans; Middle Aged; Pandemics; Phenylpropionates; Pneumonia, Viral; SARS-CoV-2 | 2020 |
A case of cefditoren-induced acute generalized exanthematous pustulosis during COVID-19 pandemics. Severe cutaneous adverse reactions are an issue.
Topics: Acute Generalized Exanthematous Pustulosis; Adrenal Cortex Hormones; Biopsy, Needle; Cephalosporins; Clinical Laboratory Techniques; Coronavirus Infections; COVID-19; COVID-19 Testing; Diagnosis, Differential; Female; Follow-Up Studies; Humans; Immunohistochemistry; Middle Aged; Obesity, Morbid; Pandemics; Pneumonia, Viral; Severe Acute Respiratory Syndrome; Severity of Illness Index; Treatment Outcome | 2020 |
A Case Series of Five People Living with HIV Hospitalized with COVID-19 in Chicago, Illinois.
Topics: Adult; Antiretroviral Therapy, Highly Active; Azithromycin; Betacoronavirus; CD4 Lymphocyte Count; Cephalosporins; Chicago; Coronavirus Infections; COVID-19; COVID-19 Drug Treatment; Female; HIV Infections; Humans; Hydroxychloroquine; Middle Aged; Pandemics; Pneumonia, Viral; Retrospective Studies; SARS-CoV-2; Serologic Tests; Treatment Outcome | 2020 |
Community use of antibiotics during the COVID-19 lockdown.
Topics: Adenoviridae; Anti-Bacterial Agents; Antimicrobial Stewardship; Azithromycin; Cephalosporins; COVID-19; COVID-19 Drug Treatment; Fluoroquinolones; Humans; Hydroxychloroquine; Incidence; Influenza A virus; Influenza B virus; Influenza, Human; Italy; Macrolides; Pandemics; Penicillins; Physical Distancing; Prescription Drug Overuse; Quarantine; Respiratory Syncytial Viruses; Respiratory Tract Infections; SARS-CoV-2 | 2021 |
A computational drug repurposing approach in identifying the cephalosporin antibiotic and anti-hepatitis C drug derivatives for COVID-19 treatment.
Topics: Ceftaroline; Cephalosporins; Coronavirus 3C Proteases; COVID-19; COVID-19 Drug Treatment; Drug Repositioning; Hepacivirus; Hepatitis C; Humans; Molecular Dynamics Simulation; Oligopeptides; SARS-CoV-2 | 2021 |
Decreased Use of Broad-Spectrum Antibiotics During the Coronavirus Disease 2019 Epidemic in South Korea.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antimicrobial Stewardship; Broadly Neutralizing Antibodies; Cephalosporins; Child; Child, Preschool; COVID-19; Female; Fluoroquinolones; Hospitalization; Humans; Infant; Infant, Newborn; Macrolides; Male; Middle Aged; Pandemics; Penicillins; Public Health; Republic of Korea; Respiratory Tract Infections; SARS-CoV-2; Young Adult | 2021 |
Emergence of Resistance to Novel Cephalosporin-β-Lactamase Inhibitor Combinations through the Modification of the Pseudomonas aeruginosa MexCD-OprJ Efflux Pump.
Topics: Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporinase; Cephalosporins; COVID-19; Humans; Microbial Sensitivity Tests; Pseudomonas; Pseudomonas aeruginosa; Pseudomonas Infections; SARS-CoV-2 | 2021 |